article fda is facing an onslaught of criticism over its handling of soy products.
The Food and Drug Administration (FDA) said this week that it is investigating whether its new labeling rules for soy products infringe on farmers’ rights.
“FDA continues to monitor the industry’s ability to comply with its labeling requirements,” the agency said in a statement.
“The agency will take appropriate actions in response to any potential violation of the agency’s labeling obligations.”
It also warned that the new rules could put the health of consumers and farmers at risk.
The FDA also said it has taken steps to make the products available in more markets, but that its actions would not be enough.
The agency has said it will consider any actions that farmers and consumers take.
In a blog post, Greenpeace USA said the FDA’s proposed rules were not needed, since many soy products are already labeled as safe.
“These new regulations would allow companies to claim a higher safety rating than is needed for their soy products,” Greenpeace wrote.
“We call on FDA to reconsider these proposed rules and instead make soy safe and safe-sounding products available for consumers.”
Greenpeace also said the rules would allow agribusiness to “make more money from consumers and the environment, and to sell more soy products to consumers than they currently can.”